Salbutamol Novolizer (salbutamol dry-powder inhaler)
/ Viatris
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 18, 2026
222725: Depemokimab as an Extended treatmeNt DURation biologic in Adults with COPD and type 2 inflammation (ENDURA-1).
(clinicaltrialsregister.eu)
- P2/3 | N=327 | Recruiting | Sponsor: Glaxosmithkline Research & Development Limited
New P2/3 trial • Chronic Obstructive Pulmonary Disease • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases
February 18, 2026
222714: Depemokimab as an Extended treatmeNt DURation biologic in Adults with COPD and type 2 inflammation (ENDURA-1).
(clinicaltrialsregister.eu)
- P2/3 | N=453 | Recruiting | Sponsor: Glaxosmithkline Research & Development Limited
New P2/3 trial • Chronic Obstructive Pulmonary Disease • Immunology • Inflammation • Pulmonary Disease • Respiratory Diseases
1 to 2
Of
2
Go to page
1